The DOI matches its Crossref record.
Tardive Dyskinesia in Patients Treated with Major Neuroleptics: A Review of the Literature
Abstract
Since 1959 a growing number of reports have described a new type of neurological disorder in mental patients. This disorder, known as tardive dyskinesia, has been observed in approximately 500 cases but, judging from the accurate observations made by three separate groups of investigators, the syndrome is likely to be more frequent than one may suspect. Although manifestations of tardive dyskinesia occur in a number of diseases of the central nervous system, there is considerable evidence that the largescale use of phenothiazines or similar drugs in recent years is responsible for the great number of patients in mental hospitals exhibiting myoclonia and choreo-athetoid symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane, J. M. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040069010 · Cited by 656
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs
Marsden, C. D., & Jenner, P. (1980) · Psychological Medicine · doi:10.1017/s003329170003960x · Cited by 449
Tarsy, D., & Baldessarini, R. J. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90084-7 · Cited by 446
Owens, D. G. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290040052008 · Cited by 336
Important Issues in the Drug Treatment of Schizophrenia
Davis, J. M., Schaffer, C. B., Killian, G. A., Kinard, C., & Chan, C. (1980) · Schizophrenia Bulletin · doi:10.1093/schbul/6.1.70 · Cited by 284
An experimental model of tardive dyskinesia
Klawans, H. L., & Rubovits, R. (1972) · Journal of Neural Transmission · doi:10.1007/bf01245320 · Cited by 275
Historical perspectives on tardive dyskinesia
Caroff, S. N., Ungvari, G. S., & Cunningham Owens, D. G. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.02.015 · Cited by 55
Metadata
- Authors
- CRANE, G. E.
- Venue
- American Journal of Psychiatry
- Published
- 1968-02
- Volume
- 124
- Issue
- 8S
- Pages
- 40-48
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2115674974
- Cited by
- 235
- References
- 0
- FWCI
- 24.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.